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Primary human dendritic cells (DC) were used to explore the inflammatory effectors,
including cytokines and microRNAs, regulated by Helicobacter pylori. In a 48 h ex-vivo
co-culture system, both H. pylori B38 and B45 strains activated human DCs and promoted
a strong inflammatory response characterized by the early production of pro-inflammatory
TNFα and IL-6 cytokines, followed by IL-10, IL-1β, and IL-23 secretion. IL-23 was
the only cytokine dependent on the cag pathogenicity island status of the bacterial
strains. DC activation and cytokine production were accompanied by an early miR-146a
upregulation followed by a strong miR-155 induction, which mainly controlled TNFα
production. These results pave the way for further investigations into the nature of H. pylori
antigens and the subsequently activated signaling pathways involved in the inflammatory
response to H. pylori infection, the deregulation of which may likely contribute to gastric
lymphomagenesis.
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INTRODUCTION
Helicobacter pylori infection causes a chronic gastric mucosal
inflammation, leading to peptic ulcer disease in 5–10% of the
infected people, and to gastric adenocarcinoma and low-grade
mucosa-associated lymphoid tissue (MALT) lymphoma in 1% of
the cases. The pathogenesis of H. pylori infection has been linked
to the strength of inflammation it promotes, which is correlated
to the functionality of the cag pathogenicity island (PAI) in the
bacteria (Censini et al., 1996). Gastric epithelial cells constitute
the first line of defense against H. pylori; they produce inter-
leukin (IL)-8, which promotes the recruitment of polynuclear
cells. Immune cells including macrophages, dendritic cells (DC)
and mucosa infiltrating lymphocytes take part in the innate and
adaptative immune responses to the bacteria.
The pro-inflammatory properties of H. pylori strains have
been mainly evaluated by measuring IL-8 production of the
AGS gastric epithelial cell line, but they deserve to be inves-
tigated on immune cells due to their orchestrated pro- and
anti-inflammatory cytokine production in response to pathogens.
In vivo the professional antigen-presenting DC were found to be
recruited into the gastric mucosa and, due to the emission of
dendrites inserting themselves between epithelial cell tight junc-
tions, they may be able to interact with H. pylori (Rescigno et al.,
2008; Shiu and Blanchard, 2013). Their role in H. pylori-induced
inflammatory response needs to be clarified.
Host defense against pathogens requires the induction
of appropriate innate immune responses, as excessive or
inappropriate activation of the immune system can be deleterious
to the organism. Therefore, various immune regulators, including
microRNAs (miRNA), also take part in the immune responses
(Baltimore et al., 2008). MiRNA received considerable attention
because of their implication inmaintaining homeostasis in funda-
mental biological processes in non-pathological states, and their
deregulation in pathological states (Sonkoly and Pivarcsi, 2009).
Changes in miRNA expression in response to bacterial infection
have been reported, including H. pylori infection in the gastric
mucosa, in gastric epithelial cells and in immune cells (Zhang
et al., 2008; Fassi Fehri et al., 2010; Belair et al., 2011; Matsushima
et al., 2011).
In the present study, primary human DCs were used
to explore the inflammatory effectors induced by H. pylori
strains. Two fully sequenced H. pylori strains were included
for this purpose, i.e., strains B38 (Thiberge et al., 2010)
and B45 (Lehours et al., 2011) which are cagPAI negative
and cagPAI positive, respectively. In parallel to cytokine pro-
duction, miRNA changes induced by H. pylori were ana-
lyzed; they included measuring miR-146 and miR-155, to
which specific immunomodulatory functions in H. pylori
infection were assigned after performing loss of function
experiments.
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MATERIALS AND METHODS
ETHICS STATEMENT
Written consent of hemochromatosis patients was obtained and
approved by the French Ministry of Research and the French
Aquitaine Limousin Blood Bank’s (Bordeaux, France) ethics com-
mittee (approval number DC-2012-1648).
In vitro GENERATION OF DCs
All tissue culture reagents were purchased at Invitrogen (Marly Le
Roi, France). Peripheral blood mononuclear cells (PBMC) from
hemochromatosis patients were isolated by centrifugation on a
Ficoll gradient and captured using magnetic CD14 microbeads
(Miltenyi Biotec, Paris, France), according to the manufacturer’s
protocol. To generate immature DCs, monocytes were grown
for 7 days in the presence of GM-CSF (50 ng/ml) and IL-4
(25 ng/ml) in RPMI-1640 medium supplemented with 10% heat-
decomplemented fetal calf serum, 2mM of L-glutamine, and
50μg/ml of vancomycin (Sandoz, Levallois Perret, France) at
37◦C in a 5% CO2 atmosphere.
CULTURE OF H. pylori STRAINS
B38 is a cagPAI negative strain, harboring the vacA s2(i2)m2
allele. B45 is a cagPAI positive strain, harboring the vacA s1(i1)m1
allele (Lehours et al., 2004b; Thiberge et al., 2010; Lehours et al.,
2011). The P12 H. pylori strain or its cagPAI isogenic dele-
tion mutant (kindly provided by R. Peek, Vanderbilt University,
Nashville, TN, USA) as well as 6 cagPAI positive and 6 cagPAI
negative ulcer-associated strains (Lehours et al., 2004a) were
also included. All strains were cultivated for 48 h at 37◦C under
microaerobic conditions (5% O2) on selective agar consisting of
21.5 g of Wilkins Chalgren agar, 50ml of human blood, 10μg/ml
of vancomycin, 10μg/ml of cefsulodin, 5μg/ml of trimethoprim,
and 10μg/ml of amphotericin B.
CO-CULTURES OF IMMATURE DCs AND H. pylori STRAINS
Immature DCs were washed once in PBS and plated onto 24-
well plastic plates at a density of 5.105 cells per well in 1ml of
RPMI-1640 growth medium. Bacteria were recovered from the
agar plates using a swab and resuspended in RPMI-1640 growth
medium at an optical density of 0.6 at 600 nm, which corre-
sponds to 3.107 CFU/ml. The bacteria were added to the DCs
at the indicated multiplicity of infection (MOI) 1 and the co-
cultures were further incubated at 37◦C in a 5% CO2 atmosphere
for 48 h.
DENDRITIC CELL ACTIVATION AND CYTOKINE ANALYSIS
The DC surface activation markers CD40, CD80, CD83, CD86,
and HLA-DR, as well as the following secreted cytokines, IL-2,
IL-4, IL-6, IL-10, and TNFα, were evaluated by flow cytome-
try using the Human Cytokine Bead Array Th1/Th2/Th17 Kit
(Becton Dickinson, Le Pont de Claix, France). IL-8, IL-12, IL-
1β, and IL-23 production was assessed by ELISA (Ready–SET–Go,
eBioscience, San Diego, CA, USA). DCs alone or stimulated
with Escherichia coli lipopolysaccharide (LPS) (100 ng/ml) (Sigma
Aldrich, St Quentin Fallavier, France) were used as negative or
positive controls for DC activation, respectively.
DENDRITIC CELL APOPTOSIS
The occurrence of DC apoptosis was assessed using annexin V
staining and propidium iodure incorporation. DCs were cen-
trifuged at 2000 rpm for 10min at 4◦C, washed once in cold PBS
and resuspended in 25μL of 0.01M HEPES (pH 7.4), 0.14M
NaCl, and 0.25mM CaCl2. The cells were labeled with 2.5μL
of anti-annexin V antibody (eBioscience) and 1μL of propid-
ium iodure (1mg/mL) (Sigma Aldrich) for 15min at 4◦C and
analyzed by flow cytometry.
OLIGONUCLEOTIDE TRANSFECTION
Transfections were performed in 24-well plates using lipo-
fectamin 2000 (Invitrogen) according to manufacturer’s
instructions, except that 5μl/well were used. DCs were trans-
fected twice (at day −2 and then 2 h before infection) with
100 nM of antisense miRNA (as155 or as146) or scram-
bled locked-nucleic-acid (LNA)-modified oligonucleotides
(Table A1).
RNA EXTRACTION AND miRNA QUANTITATIVE RT-PCR
DCs were collected in Eppendorf tubes and pelleted by
centrifugation at 2000 rpm for 5min at room tempera-
ture. Total RNA was extracted from the DC pellet using
a Trizol reagent (Invitrogen), according to manufacturer’s
instructions. RNA concentrations were determined by spec-
trophotometry (NanoDrop Technologies, Wilmington, DE,
USA). RNA quality was determined on an Agilent 2100
Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA). For
miRNA quantitations, 250 ng of total RNA were retrotran-
scribed using the miScript Reverse Transcription kit (Qiagen,
Courtaboeuf, France) and qPCR was performed using a SYBr
Green PCR kit and hsa-miR-155, hsa-miR-146a and SNOR25
specific primers (Qiagen), according to the manufacturer’s
instructions. The amplification profiles were measured on a
Stratagene Mx3005P instrument (Life Technologies, Saint Aubin,
France).
STATISTICAL ANALYSIS
Data were expressed as a ratio of fold induction compared to non-
activated DCs. For each experiment, all experimental conditions
were tested three times and each experiment was conducted at
least three times for each strain. Statistical analyses were done
using the non-parametric Mann-Whitney test. A p-value of less
than 0.05 was considered significant. All statistics were performed
using SPSS 16.0F for Windows software (SPSS Inc., Chicago,
IL, USA).
RESULTS
DENDRITIC CELL ACTIVATION BY H. pylori
The nature, the amount and the duration of the antigenic stimu-
lation are important factors that can influence the inflammatory
and molecular responses of DCs. Before infection, the imma-
ture DC phenotype (CD1a +, HLA-DR +, CD80 −, CD86 −,
CD14 −, CD83−) was verified by flow cytometry (Figure A1).
Our preliminary experiments showed that H. pylori at MOI 1
significantly activated DCs (Figure A2), with minimal apoptosis
(less than 10%) (Figure A3).
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CYTOKINE PRODUCTION IN H. pylori-ACTIVATED DCs
DCs activated by either the B38 or B45 strain at MOI 1
or by E. coli LPS secreted significant amounts of TNFα, IL-
1β, IL-6, IL-8, IL-10, IL-12, and IL-23, but not IL-2, IL-4,
IL-17, TGFβ, or INFγ compared to non-activated DCs. H.
pylori-activated DCs produced mainly TNFα (1500–2000 fold
stimulated production over basal level), and in a decreas-
ing order of stimulation, IL-6 (1000-fold), IL-10 (200–400
fold), IL-1β (150-fold), IL-23 (50–100 fold), IL-8 (10-fold)
and IL-12 (5-fold) after 48 h of co-culture. The cytokine lev-
els were low or nil in non-activated DC supernatants, except
for IL-8 and IL-12 which were already secreted under basal
conditions.
H. pylori-activated DCs produced the same cytokines as LPS-
activated DCs, both qualitatively and quantitatively, except for
IL-10 (Figure 1). This potent anti-inflammatory molecule was
found at a significantly higher level upon stimulation by both H.
pylori B38 and B45 than by LPS. Moreover, compared to E. coli
LPS, IL-10 production was significantly induced by H. pylori B38
strain as early as 6 h.
Analysis of cytokine production kinetics in H. pylori-activated
DCs revealed the early, massive production of TNFα (Figure 1).
TNFα reached its maximal level as early as 6 h in the presence
of LPS or the bacteria, and remained quite stable thereafter. IL-6
was maximally stimulated by E. coli LPS as early as 6 h, and
progressively with H. pylori (Figure 1).
There was generally no significant difference in the cytokine
production between the two H. pylori strains, except for IL-23, a
major cytokine involved in Th17 response, which was higher with
B45 than with B38 (Figure 1). This difference could be attributed
to the presence of the cagPAI in the B45 strain. To test this hypoth-
esis, DCs were activated for 48 h by either H. pylori P12 strain or
its isogenic cagPAI deletion mutant (Figure 1), and by 12moreH.
pylori strains tested individually (6 cagPAI positive and 6 cagPAI
negative) from our collection (Lehours et al., 2004a) (Figure 1).
IL-23 secretion was significantly lower with the P12 mutant and
the cagPAI negative strains than with the P12 wild type and the
cagPAI positive strains confirming the positive influence of the
cagPAI gene products on the secretion of this cytokine. IL-23
secretion started rather late following H. pylori infection, at 48 h
FIGURE 1 | Cytokine production in H. pylori -activated dendritic cells.
(A) Kinetics of TNFα, IL-6, and IL-10 secretion by E. coli LPS- or H.
pylori-activated dendritic cells. DCs were either stimulated with E. coli LPS
(100ng/ml) or cocultivated with B38 H. pylori strain at MOI 1 for 6, 24, or
48h. TNFα, IL-6, and IL-10 secretion in the culture supernantants was
evaluated by flow cytometry (as described in Materials and Methods). The
horizontal bar across the box indicates the median and the capped bars
indicate the minimum and maximum data values of fold induction ratio vs.
DCs alone obtained for 6 independent experiments corresponding to 6
different donors. These results are representative of the results obtained
for H. pylori strain B45 for the same experiments. *for p < 0.05 and NS
for p > 0.05 compared to E. coli LPS at the corresponding time-point.
(B) Influence of the H. pylori cagPAI on the production of IL-23 by dendritic
cells after H. pylori infection. (1) DCs were cocultured with B38 or B45
H. pylori strain at MOI 1 for 6, 24, or 48h. IL-23 levels in culture
supernatants were measured by ELISA. The horizontal bar across the box
indicates the median and the capped bars indicate the minimum and
maximum data values of fold induction ratio vs. non-activated DCs, for 6
independent experiments for each strain and for 6 different donors. *for
p < 0.05 between the H. pylori strains B38 and B45 at the corresponding
time-point. (2) DCs were cocultured for 48h with H. pylori strain P12 and
its isogenic cagPAI mutant (KO-P12) at MOI 1 or (3) with 12
ulcer-associated H. pylori strains tested individually (6 cagPAI positive and
6 cagPAI negative). IL-23 levels in culture supernatants were measured by
ELISA. The horizontal bar across the box indicates the median and the
capped bars indicate the minimum and maximum data values of fold
induction ratio vs. non-activated DCs, for 3 independent experiments for
each group of strains and for three different donors (*if p < 0.05).
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for B38 and 24 h for B45 (Figure 1). Finally, both LPS- and H.
pylori-mediated activation displayed similar patterns of progres-
sive production of IL-1β, IL-8, and IL-12 over the time course
(Figure A4).
EXPRESSION OF miRNA IN H. pylori-ACTIVATED DCs
MiRNAs, differentially regulated in H. pylori-activated DCs as
compared to immature DCs, were investigated using a qPCR
array of 88 miRNA involved in human immunopathology.
Among the screened miRNAs, 12 showed the highest induction
levels (3–21 fold) and 13 the strongest repression (3–6 fold)
(Table A1). Nevertheless, taking into account only those that
were expressed the most upon induction (over 1/100 of average
housekeeping genes), we identified miR-187, miR-155, miR-146a,
let-7e, miR-29b, miR-34, miR-214, and miR-147 as being sub-
stantially upregulated following H. pylori infection. The relatively
abundant miR-152, miR-195, miR-16, miR-30c, miR-223, miR-
126, miR-574-3p, miR-21, and miR125b were found to be the
most repressed by the bacteria (Table 1).
Kinetic analyses of miR-146 and miR-155 expression in DCs
co-cultured with either the B38 or the B45 strain atMOI 1 showed
that both miRNAs were upregulated as early as 6 h post-infection
and increased progressively thereafter (Figure 2A). Whereas miR-
146a reached 50% of its maximal stimulation as early as 6 h
post-infection, miR-155 was dramatically upregulated between
6 and 24 h. Thus, at 48 h post-infection, miR-146 levels were
increased by 5–10 fold over the basal level, and miR-155 by
100–200 fold. The statistical analysis of 13 independent experi-
ments showed no significant difference between the B38 and B45
strains in their ability to upregulate the miRNAs, since miR146a
expression was enhanced by 4.06 ± 0.47 and 4.8 ± 0.78 fold (p =
0.927), and miR-155 by 84.03 ± 15.87 and 99.17 ± 26.94 fold
(p = 0.224), respectively. This suggests that the miRNA response
of H. pylori-activated DC was independent of the strain’s cagPAI
status. miR-146a was upregulated more by the H. pylori strains
than by LPS, contrary to miR-155, which reached the same inten-
sity after LPS stimulation as after co-culture with either of the
H. pylori strains (Figure 2A). At 48 h post-infection, miR-146a
upregulation was positively correlated with a MOI up to 40,
whereas miR-155 upregulation peaked at MOI 1–5 and decreased
at higher ones (Figure 2B). The global results indicate that miR-
146a and miR-155 upregulations take part in the DC immune
response to H. pylori, independently of their cagPAI status, with
miR-146a upregulation preceding the massive miR-155 biosyn-
thesis.
In order to investigate the importance of these miRNAs in the
regulation of cytokine production upon infection, their mature
forms were functionally inhibited using antisense oligonu-
cleotides (or their scrambled controls), which were introduced
into immature DCs using lipofectamin prior to the LPS or
H. pylori challenge. Both miR-146a and miR-155 knockdown had
little influence on the LPS- or H. pylori-mediated upregulation
of DC surface activation markers, suggesting that neither one
was required for this process (data not shown). Anti-miR-146
antisense oligonucleotides totally prevented LPS- or H. pylori-
triggered miR-146 upregulation (Figure 3A) and had no influ-
ence on the level of miR-155 induction, and vice versa, showing
Table 1 | miRNA differentially regulated in H. pylori B38-activated
dendritic cells.
Up-regulated Fold change Relative level in
miRNA upon infection infected cells
hsa-miR-187 21.0756 0.0515
hsa-miR-155 13.4310 2.5491
hsa-miR-198 7.6079 0.0023
hsa-miR-135b 6.5319 0.0049
hsa-miR-299-3p 5.5693 0.0020
hsa-miR-451 4.8821 0.0052
hsa-miR-146a 4.8149 21.8566
hsa-let-7e 4.7816 2.4284
hsa-miR-184 4.3094 0.0016
hsa-miR-29b 4.2797 0.1216
hsa-miR-34a 4.1339 0.7738
hsa-miR-214 4.1626 0.0110
hsa-miR-206 3.1987 0.0046
hsa-miR-147 3.0898 0.3276
hsa-miR-302a 3.0262 0.0015
Downregulated Fold change Relative
miRNA upon infection initial level
hsa-miR-409-3p 0.1728 0.0904
hsa-miR-152 0.2070 0.2897
hsa-miR-150 0.2113 0.0333
hsa-miR-195 0.2584 145.2606
hsa-miR-16 0.2675 202.6014
hsa-miR-30c 0.3051 12.6626
hsa-miR-223 0.3115 143.2608
hsa-miR-126 0.3248 1.6386
hsa-miR-574-3p 0.3270 1.3218
hsa-miR-21 0.3293 1307.4137
hsa-miR-203 0.3362 0.0168
hsa-mir-125b 0.3529 1.9219
One μg of total RNA from DCs cultured for 48 h in the absence or presence
of H. pylori B38 at MOI 1 was retro-transcribed using the RT2 miRNA First
Strand Kit (Qiagen, Courtaboeuf, France). The first strand reaction was mixed
with RT2 SYBR Green qPCR mix and distributed onto PCR array plates contain-
ing primers for 88 miRNA involved in human immunopathology (SABioscience,
Qiagen) according to manufacturer’s protocol. The amplification profiles were
measured on a Stratagene Mx3005P instrument (Life Technologies, Saint Aubin,
France). Data were analyzed by the Ct method (Livak and Schmittgen, 2001),
using the average Ct of the housekeeping RNA for normalization. Data are
expressed as fold induction compared to non-activated DCs in the medium
lane. For each miRNA, the level relative to the mean expression of housekeep-
ing genes is shown in the right lane, in order to assess which miRNA may be
expressed at levels high enough to be relevant (highlighted).
the efficiency of antisenses to inhibit miRNA expression, most
likely by sequestering them. This also suggests that miR-146a and
miR-155 expression may not be correlated in this cell system.
Nevertheless, in response to H. pylori, two cytokines were clearly
affected by this treatment (Figure 3B). First, in comparison to
scrambled oligonucleotide-treated cells, TNFα production at 48 h
was induced to a 50% greater extent in anti-miR-155-treated
Frontiers in Microbiology | Microbial Immunology August 2013 | Volume 4 | Article 236 | 4
Hocès de la Guardia et al. H. pylori-regulated cytokine and miRNA in human DC
FIGURE 2 | MOI dependence and kinetic analyses of miR-146a and
miR155 expression in activated dendritic cells. (A) DCs were either
stimulated with E. coli LPS or cocultured with H. pylori strains B38 or B45
at MOI 1 for 6, 24, or 48h. (B) DCs were cocultured with H. pylori strains
B38 or B45 at MOIs ranging from 0.1 to 40 for 48h. For both experiments,
miRNA levels were determined by RT-qPCR. Data is presented as the fold
induction ratio (mean + standard deviation of duplicate) of activated vs.
non-activated DCs and is representative of one experiment out of 3.
cells notably upon H. pylori infection, whereas it was weakly
impaired (≤20%) by anti-miR-146. Second, anti-miR-146 treat-
ment clearly impaired IL-10 production upon infection, whereas
anti-miR-155 had no significant effect. miR-146a or miR-155
knockdown did not affect the cytokine response to LPS. This
treatment did not alter IL-1β or IL-8 production and only
weakly affected that of other cytokines after H. pylori challenge
(Figure A5).
DISCUSSION
In this manuscript, we aimed at analyzing the initial steps of the
immune response to H. pylori strains. We therefore developed
an ex vivo co-culture cell system, in which we showed that H.
pylori strains were able to activate primary human DCs and pro-
mote strong proinflammatory cytokine and miRNA responses.
Although most of the observed effects were independent of theH.
pylori cagPAI status, the cagPAI positive strain specifically upreg-
ulated IL-23, most likely to orientate DCs to promote a Th17
response.
Numerous articles have been published on the interac-
tion between H. pylori and DCs, however, with a huge het-
erogeneity in the bacterial strains, MOI and experimental
conditions (viable/sonicated/paraformaldehyde-treated bacteria)
(Guiney et al., 2003; Hafsi et al., 2004; Kranzer et al., 2004, 2005;
Kao et al., 2006; Mitchell et al., 2007; Rad et al., 2009; Andres
et al., 2010; Kao et al., 2010; Fehlings et al., 2012). Our data
were obtained using primary human DCs from several donors.
All experiments were repeated with at least three different donors
in order to ensure the reliability of the results. Significant produc-
tions of several cytokines (TNFα, IL-1β, IL-6, IL-8, IL-10, IL-12,
and IL-23) were observed in H. pylori-activated DCs, TNFα and
FIGURE 3 | Effect of miR-146a and miR-155 loss of function in H.
pylori -induced miRNA levels and TNFα and IL-10 production. (A)
Changes in miR-146a and mir-155 relative levels in DCs transfected with
anti-miRNA oligonucleotides: DCs were transfected with 100nM of
miRNA-antisense (anti-miR-146a or anti-miR-155) or scrambled
oligonucleotides before being challenged with B38 or B45 H. pylori strains
at MOI 1 for 48h. RTqPCR data are presented as the fold induction ratio
(mean + standard deviation of triplicates) in activated DCs and are
representative of one experiment out of 4.*if p < 0.05 compared to miRNA
levels obtained on activated DCs treated with scrambled oligonucleotides.
(B) TNFα and IL-10 production in activated DCs transfected by either
anti-miR146a or anti-miR155 oligonucleotides: DCs were transfected as in
(A) and activated with E. coli LPS (100ng/ml) or H. pylori B38 or B45 strains
at MOI 1 for 48h. TNFα and IL-10 production was evaluated by flow
cytometry. The horizontal bar across the box indicates the median and the
capped bars indicate the minimum and maximum data values of fold
induction ratio compared to scrambled oligonucleotide-treated cells for 4
independent experiments corresponding to 4 different donors (*if p < 0.05).
IL-6 being produced at the highest levels. In vivo, TNFα con-
tributes to monocyte maturation after recruitment, whereas IL-6
supports the transition between the early stages of the infection
and the sustained mononuclear influx into the infected gastric
mucosa. Early production of TNFα and IL-6 upon LPS stimula-
tion reflects the intrinsic property of E. coli LPS to trigger TLR4
signaling pathways, a property that is not shared by H. pylori
LPS (Rad et al., 2009). Delayed secretion of TNFα and IL-6 by
H. pylori-activated DCs as compared to LPS-activated ones may
depend on bacterial DNA and RNA recognition by endosomal
TLR9 and TLR8, respectively (Rad et al., 2009), a later process
when compared to the recognition of pathogen associated-motifs
by surface TLRs. At later time points (24 and 48 h), a switch in
the inflammatory response occurred with an accumulation over
time of IL-6, IL-10, IL-23, and IL-1β, without any significant
induction of TGFβ. The late IL-10 and IL-12 production by H.
pylori-activated DCs may coincide in vivo with their homing in
lymph nodes (Kranzer et al., 2004). IL-10 was secreted at a higher
level after DC activation by H. pylori than by E. coli LPS, in accor-
dance with recent data, which showed that H. pylori interactions
with both TLR2 and the lectin DC-SIGN contributed to an anti-
inflammatory environment via the release of IL-10 (Rad et al.,
2009; Fehlings et al., 2012). IL-12, which plays a role in the dif-
ferentiation of naive T cells toward Th1 cells (Pellicano et al.,
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2007), was the least produced cytokine upon DC activation. In
the present study, the high IL-10 and TNFα levels secreted by
activated DCs could be responsible for the low IL-12 secretion
due to their ability to inhibit its production (Langenkamp et al.,
2000). In addition, IL-23 was the only cytokine dependent on
the strain’s cagPAI status. This result is still a matter of debate.
Indeed several papers show that cagPAI could influence in vitro
IL-23 release by DCs (Khamri et al., 2009; Tanaka et al., 2010).
However, others argue that cagPAI does not regulate cytokine
production in DCs cocultured with H. pylori (Kao et al., 2010;
Horvath et al., 2012). Previous data from experiments on human
gastric biopsies infected with H. pylori indicate that myeloid DCs
co-localize with IL-23 and IL-17-producing, infiltrating lympho-
cytes (Khamri et al., 2010); one could therefore hypothesize that
the H. pylori B45 strain may be able to induce a Th17 response,
likelymediated by the cagPAI status. As IL-23 also plays an impor-
tant role in sustaining Th17 responses in addition to acting on
lymphoid cells to induce IL-17 (Shi et al., 2010; Hitzler et al.,
2013), signaling pathways involved in this phenomenon deserve
further investigation.
In parallel to the cytokine response profile, miR-155 and
miR-146a were co-upregulated most intensely and invariably in
activated DCs, independently of the cagPAI status of the bacte-
rial strain. These two miRNA were previously expressed at high
levels in H. pylori-infected gastric mucosa (Liu et al., 2010; Lario
et al., 2012). Our results clearly show that the extent of their
upregulation as well as their kinetics and MOI-dependence did
not evolve in parallel with the time-course of H. pylori-activated
DCs. MiR-146 upregulation takes part in the early immune pro-
gram activated in DCs by H. pylori, as it reached 50% of its
maximal 10 fold stimulation as early as 6 h post-infection, while
miR-155 was induced at a striking rate 24 h post-infection, reach-
ing 200 fold the stimulated levels at 48 h. The massive induction
of miR-155 in DCs over the time-course of their activation by
both LPS and H. pylori is consistent with previous findings
(O’Connell et al., 2007; Tili et al., 2007; Martinez-Nunez et al.,
2009). Indeed, miR-155 can be induced by pathogen-associated
ligands via TLR-, NF-κB-, and MyD 88-dependent pathways or
by several cytokines such as IL-1β (Ceppi et al., 2009) and TNFα
(Tili et al., 2007) which are both likely to sustain the high miR-
155 biosynthesis induced in LPS-stimulated or H. pylori-infected
DCs. An alternative miR-155 activation by bacterial peptidogly-
can sensing via the cytoplasmic NOD2 receptor has been reported
(Schulte et al., 2013), which may participate to the massive miR-
155 induction. Contrary to miR-146, miR-155 was induced via
a biphasic profile according to the MOI, suggesting that at a
high MOI, the increasing level of some inflammatory cytokines
might negatively regulate miR-155 expression. As the anti-
inflammatory cytokine IL-10 was found to inhibit LPS-induced
miR-155 upregulation without affecting miR-146a (McCoy et al.,
2010), it is likely that H. pylori-stimulated IL-10 produc-
tion is responsible for the decreased miR-155 upregulation at
high MOIs.
The role of miR-146 and miR-155 in the innate immune
responses was deduced from the identification of their respec-
tive targets. As miR-146a targets and silences TNF-receptor-
associated factor and IL-1β receptor-associated kinase mRNAs,
which are key adapter molecules in the TLR/ NFκB pathway,
the role of miR-146a upregulation in response to pathogens was
shown to moderate TLR-triggering of the NFκB pathway via a
negative feedback loop, thus avoiding overproduction of pro-
inflammatory IL-1β and TNFα cytokines (Taganov et al., 2006;
Nahid et al., 2009; Lu et al., 2010). A similar immune regulatory
function was assigned tomiR-155 which targets several gene tran-
scripts of the NF-κB pathway (FADD, Ripk1, IKK, and NIK), as
well as the immune cell transcription factor PU, Src homology
2 domain-containing inositol-5-phosphatase (SHIP) and CCAAT
enhancer-binding protein beta (C/EBPbeta) (Rodriguez et al.,
2007; Tili et al., 2007; Costinean et al., 2009; Schulte et al.,
2013). In addition, miR-155 also stabilizes the TNFα mRNA (Tili
et al., 2007; Semaan et al., 2011), suggesting that simultane-
ous anti- and pro-inflammatory effects of miR-155 most likely
contribute to the fine-tuning of the TNF-mediated inflamma-
tion. We assessed the role of miR-146 and miR-155 in the DC
cytokine response to H. pylori using specific antisenses to each
miRNA, which inhibit their silencing function by competition
with their binding sites on mRNA targets. Thus, the most notice-
able effect of miR-155 loss of function in our cell system was
an enhanced TNFα production by H. pylori, an effect consistent
with the immunomodulatory role assigned to miR-155 upregu-
lation in response to microbial stimuli (O’Connell et al., 2007;
Rodriguez et al., 2007; Ceppi et al., 2009; Martinez-Nunez et al.,
2009). Enhanced TNFα response to H. pylori in the absence of
miR-155 may also be facilitated by the downregulation of miR-
125b which we observed in our microarray (Table 1), and which
directly targets TNFα (Tili et al., 2007). In our miR-146 loss of
function experiment, no cytokine response was markedly altered
with the exception of IL-10. The impaired production of this
anti-inflammatory cytokine in response toH. pylori is concordant
with the previously established immunomodulatory role of miR-
146 upon infection, but it was not accompanied by an enhanced
production of inflammatory cytokines in anti-miR-146-treated
cells as expected. A possible explanation for the decreased IL-10
response to H. pylori in the absence of miR-146 could be that
miR-146 loss of function unmasks the regulatory effects of other
miRNAs: for instance, let-7e, which directly targets IL-10 (Schulte
et al., 2011) was upregulated in H. pylori-activated DCs (Table 1)
and may subsequently negatively regulate IL-10. The differences
in the effects of miR-146 and miR-155 knockdown, which stress
the prominent role of miR-155 in H. pylori-activated DCs, could
be related to different functional specializations of these two
seemingly co-induced miRNAs, as recently reported in LPS-
stimulated murine macrophages (Schulte et al., 2013); miR-146
responded to sub-inflammatory stimuli to prevent TLR activa-
tion, and miR-155 responded to pro-inflammatory stimuli as a
global limiter of the inflammatory response. Our experimental
conditions established a TNFα-filled, pro-inflammatory environ-
ment in cultured DCs, and thus preferentially elicited miR-155
functions.
miR-146a and miR-155 expressions may be of special inter-
est in H. pylori-mediated immune pathologies, because they
are associated with NFκB activation, a pathway strongly acti-
vated during H. pylori infection and in H. pylori-driven MALT
lymphoma. High expression of miR-146a was associated with
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chronic inflammatory diseases (Sonkoly and Pivarcsi, 2009) and
miR-155 represents an important element in B cell lymphoma
development (Costinean et al., 2006), indicating that alterations
in the fine-tuning of innate immune responses by miRNAs may
contribute to inflammatory disorders. Other miRNAs, which are
differentially regulated inH. pylori-activated DCs, deserve further
investigation; among them, miR-187, which was strongly upreg-
ulated in the H. pylori-activated DCs, could control IL-10-driven
anti-inflammatory responses (Rossato et al., 2012).
In conclusion, the co-culture cell system presented here
allowed the identification of pro- and anti-inflammatory effectors
in response to H. pylori and revealed the influence of the cagPAI
on the immune responses. These important findings pave the
way for further investigations on the nature of H. pylori antigens
and the subsequently activated signaling pathways involved in the
inflammatory response to H. pylori infection.
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APPENDIX
Table A1 | MiRNA microarray data in uninfected DC (control) and DCs infected for 48 h by H. pylori B38 strain at MOI 1.
Mature miRNA ID Ct control DC Ct B38-infected Rel value in control Rel value in B38-infected Fold change upon infection
hsa-let-7a 21.6 18.34 2.7368 4.3169 1.5773
hsa-let-7c 29.79 26.4 0.0094 0.0162 1.7261
hsa-let-7d 25.72 22.11 0.1574 0.3164 2.0104
hsa-let-7e 24.03 19.17 0.5079 2.4284 4.7816
hsa-let-7g 21.28 17.74 3.4165 6.5432 1.9152
hsa-miR-103 20.51 17.97 5.8260 5.5790 0.9576
hsa-miR-106a 19.89 18 8.9538 5.4642 0.6103
hsa-miR-125a-5p 19.32 17.27 13.2921 9.0631 0.6818
hsa-mir-125b 22.11 21.01 1.9219 0.6783 0.3529
hsa-miR-126 22.34 21.36 1.6386 0.5322 0.3248
hsa-miR-128 23.57 22.36 0.6986 0.2661 0.3809
hsa-miR-130a 30.73 27.14 0.0049 0.0097 1.9827
hsa-miR-132 21.35 19.8 3.2546 1.5692 0.4821
hsa-miR-135b 33.42 28.11 0.0008 0.0049 6.5319
hsa-miR-138 31.96 28.63 0.0021 0.0034 1.6558
hsa-miR-142-3p 18.17 15.83 29.4971 24.5900 0.8336
hsa-miR-142-5p 21.05 19.47 4.0069 1.9725 0.4923
hsa-miR-143 28.96 27.05 0.0167 0.0103 0.6188
hsa-miR-145 29.57 27.39 0.0109 0.0081 0.7461
hsa-miR-146a 20.87 16 4.5394 21.8566 4.8149
hsa-miR-147 26.29 22.06 0.1060 0.3276 3.0898
hsa-miR-148a 23.17 21.27 0.9218 0.5664 0.6145
hsa-miR-150 27.96 27.6 0.0333 0.0070 0.2113
hsa-miR-152 24.84 24.51 0.2897 0.0600 0.2070
hsa-miR-155 25.45 19.1 0.1898 2.5491 13.4310
hsa-miR-15a 22.35 19.39 1.6273 2.0849 1.2812
hsa-miR-15b 21.33 19.35 3.3001 2.1435 0.6495
hsa-miR-16 15.39 14.69 202.6014 54.1917 0.2675
hsa-miR-181a 25.92 22.12 0.1370 0.3143 2.2934
hsa-miR-182 29.4 27.82 0.0123 0.0060 0.4923
hsa-miR-183 32.22 29.45 0.0017 0.0020 1.1231
hsa-miR-184 34.48 29.77 0.0004 0.0016 4.3094
hsa-miR-185 23.65 21.63 0.6609 0.4414 0.6678
hsa-miR-186 24.85 21.41 0.2877 0.5141 1.7870
hsa-miR-187 31.73 24.73 0.0024 0.0515 21.0756
hsa-miR-18a 21.9 20.46 2.2230 0.9931 0.4467
hsa-miR-18b 28.4 25.7 0.0246 0.0263 1.0699
hsa-miR-191 18.39 17.18 25.3252 9.6465 0.3809
hsa-miR-194 25.03 23.52 0.2539 0.1191 0.4689
hsa-miR-195 15.87 15.22 145.2606 37.5307 0.2584
hsa-miR-196a 32.29 29.02 0.0017 0.0026 1.5883
hsa-miR-198 34.73 29.2 0.0003 0.0023 7.6079
hsa-miR-19a 18.9 16.6 17.7839 14.4200 0.8108
hsa-miR-19b 19.13 16.88 15.1632 11.8762 0.7832
hsa-miR-200a 31.24 29.64 0.0034 0.0017 0.4991
hsa-miR-203 28.95 27.92 0.0168 0.0056 0.3362
hsa-miR-205 31.25 30.96 0.0034 0.0007 0.2013
hsa-miR-206 32.49 28.21 0.0014 0.0046 3.1987
hsa-miR-20a 19.34 17.42 13.1091 8.1681 0.6231
hsa-miR-20b 20.8 19.06 4.7651 2.6208 0.5500
(Continued)
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Table A1 | Continued
Mature miRNA ID Ct control DC Ct B38-infected Rel value in control Rel value in B38-infected Fold change upon infection
hsa-miR-21 12.7 11.7 1307.4137 430.5390 0.3293
hsa-miR-210 25.13 21.08 0.2369 0.6462 2.7274
hsa-miR-214 31.61 26.95 0.0027 0.0110 4.1626
hsa-miR-223 15.89 14.97 143.2608 44.6318 0.3115
hsa-miR-23b 22.38 20.89 1.5938 0.7371 0.4625
hsa-miR-26a 18.23 16.05 28.2955 21.1121 0.7461
hsa-miR-26b 18.8 16.95 19.0603 11.3137 0.5936
hsa-miR-27a 17.31 15.27 53.5383 36.2523 0.6771
hsa-miR-27b 22.41 20.95 1.5610 0.7071 0.4530
hsa-miR-299-3p 34.48 29.4 0.0004 0.0020 5.5693
hsa-miR-29b 28.19 23.49 0.0284 0.1216 4.2797
hsa-miR-29c 23.17 19.64 0.9218 1.7532 1.9020
hsa-miR-302a 34.03 29.83 0.0005 0.0015 3.0262
hsa-miR-30b 19.66 18.3 10.5013 4.4383 0.4226
hsa-miR-30c 19.39 18.5 12.6626 3.8637 0.3051
hsa-miR-30e 22.43 19.82 1.5395 1.5476 1.0052
hsa-miR-335 28.9 27.56 0.0174 0.0072 0.4168
hsa-miR-34a 25.47 20.82 0.1872 0.7738 4.1339
hsa-miR-363 25.96 24.12 0.1333 0.0786 0.5895
hsa-miR-370 26.25 24.36 0.1090 0.0665 0.6103
hsa-miR-409-3p 26.52 26.45 0.0904 0.0156 0.1728
hsa-miR-451 32.92 28.03 0.0011 0.0052 4.8821
hsa-miR-493 31.14 29.19 0.0037 0.0023 0.6362
hsa-miR-574-3p 22.65 21.66 1.3218 0.4323 0.3270
hsa-miR-9 25.47 22.79 0.1872 0.1975 1.0552
hsa-miR-98 24.74 22.01 0.3105 0.3392 1.0924
hsa-miR-99b 21.24 19.79 3.5125 1.5801 0.4498
SNORD48 26.92 23.15
SNORD47 22.99 20.79
SNORD44 19.91 18.54
RNU6-2 22.39 19.32
HKG mean Ct 23.0525 20.45
One μg of total RNA from DCs cultured for 48 h in the absence or presence of H. pylori B38 at MOI 1 was retro-transcribed using the RT2 miRNA First Strand Kit
(Qiagen, Courtaboeuf, France). The first strand reaction was mixed with RT2 SYBR Green qPCR mix and distributed onto PCR array plates containing primers for
88 miRNA involved in human immunopathology (SABioscience, Qiagen) according to the manufacturer’s protocol. The amplification profiles were measured on a
Stratagene Mx3005P instrument (Life Technologies, Saint Aubin, France). The relative value for each miRNA was calculated by the Ct method taking account the
mean Ct for housekeeping genes (HKG). The fold induction of each miRNA corresponds to the ratio of its relative value in B38-infected DCs versus its relative value
in control DCs.
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FIGURE A1 | Characterization of the immature state of dendritic cells
after 7 days of differentiation with GM-CSF and IL-4 as determined by
flow cytometry. After 7 days of culture in the presence of GM-CSF and IL-4,
DCs were labeled with the following antibodies: CD14-FITC, CD1a-FITC,
CD40-PE, CD80-PE, CD83-FITC, CD86-PE, and HLA-DR-PECy5. They were
analyzed by flow cytometry using a Canto II cytometer (Becton Dickinson, Le
Pont de Claix, France). The percentages of positively labeled cells were
determined after subtraction of the isotype control values (black histograms
on the top of the figure) and are presented in gray histograms for each
surface marker. In mature DCs, CD40, CD80, CD83, and CD86 were low in
accordance with a non-activated stage. A high proportion of DCs expressed
the CD1a and HLA-DR molecules. For each activation marker data
[percentage of positive cells + mean fluorescence intensity (MFI)] are
indicated. One representative experiment out of 13 is shown.
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FIGURE A2 | Upregulation of HLA-DR, CD86, CD40, and CD83 expression
in activated dendritic cells. Dot plots on the left side of the figure
correspond to DCs stained with C83-FITC and CD86-PE antibodies and dot
plots on the right side to DCs stained with C40-FITC and HLA-DR-PECy5
antibodies. E. coli LPS (LPS, 100ng/ml) was used as the positive control.
For each activation marker, the percentage of positive cells and mean
fluorescence intensity (MFI) are indicated on each corresponding axis and
are representative of the data obtained for one experiment out of 13
performed for H. pylori strain B38 and strain B45. (PE: phycoerythrine,
PECy5: phycoerythrine-cyanine 5, FITC: fluorescein isothiocyanate).
FIGURE A3 | Apoptosis rate in dendritic cell apoptosis activated
by H. pylori. DCs were cocultivated for 48h with B38 or B45 H. pylori
strain at MOI 1. The cells were labeled with anti-annexin V-FITC
antibody and propidium iodure and analyzed by flow cytometry.
Percentages of viable DCs (double negative cells in Q3), necrotic DCs
(propidium iodure positive-FITC negative in Q1), and apoptotic DCs
(FITC-positive, propidium iodure ± in Q2 and Q4) are depicted in each
area. The percentages are shown for one representative experiment
out of 3 independent experiments (y-axis, propidium iodure; x-axis,
anti-annexin V-FITC) (NI for uninfected DCs).
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FIGURE A4 | Kinetics of IL-1β, IL-8 and IL-12 production by E. coli
LPS- or H. pylori -activated dendritic cells. DCs were either
stimulated with E. coli LPS (100ng/mL) or cocultivated with H. pylori
B38 strain at MOI 1 for 6, 24, or 48h. IL-1β, IL-8, and IL-12 secretion
levels were assessed by ELISA (as described in Material and
Methods). The horizontal bar across the box indicates the median and
the capped bars indicate the minimum and maximum data values of
fold induction ratio vs. DCs alone obtained for 6 independent
experiments corresponding to 6 different donors. These results are
representative of those obtained for H. pylori B45 strain-activated DC
performed in parallel during the same experiments. NS for p > 0.05
compared to E. coli LPS-activated DC at the corresponding time-point.
FIGURE A5 | Effect of miR-146a or miR-155 loss of function on
H. pylori -induced IL-23, IL-6, IL-12, IL-1β and IL-8 production. DCs were
transfected with 100nM of miRNA-antisense (anti-miR-146a or anti-miR-155)
or scrambled oligonucleotides before being challenged with B38 or B45
H. pylori strains at MOI 1 for 48h. IL-6 secretion was evaluated by flow
cytometry, whereas IL-1β, IL-8, IL-12, and IL-23 production were assessed by
ELISA. The horizontal bar across the box indicates the median and the
capped bars indicate the minimum and maximum data values of fold
induction ratio compared to scrambled oligonucleotide-treated cells, for 4
independent experiments corresponding to 4 different donors (*if p < 0.05).
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